My hunch is it is to do with XV Ventilation (XV) FDA approval forward from it's clearance in Mar 2020 OR maybe a early TGA pre submission update OR maybe regulatory approval in another part of the world. However I'm a bit confused as 4dx is implementing a SaaS model rather than an actual "medical device" as such.
Unless someone can shed more light around this space.
My hunch is it is to do with XV Ventilation (XV) FDA approval...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.0¢ |
Change
0.015(2.75%) |
Mkt cap ! $229.8M | |||
| Open | High | Low | Value | Volume |
| 55.5¢ | 57.0¢ | 55.5¢ | $178.2K | 317.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 38625 | 56.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 57.0¢ | 23519 | 2 |
View Market Depth
| Last trade - 16.10pm 02/07/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |